DIVAn ethnography about the work of genome scientists, entrepreneurs, and policy makers in biotech drug development in the United States and India./div

From call centers, overseas domestic labor, and customer care to human organ selling, gestational surrogacy, and knowledge work, such as software programming, life itself is channeled across the globe from one population to another. In Life Support, Kalindi Vora demonstrates how biological bodies have become a new kind of global biocapital. Vora examines how forms of labor serve to support life in the United States at the expense of the lives of people in India. She exposes the ways in which even seemingly inalienable aspects of human life such as care, love, and trust—as well as biological bodies and organs—are not only commodifiable entities but also components essential to contemporary capitalism. As with earlier modes of accumulation, this new global economy has come to rely on the reproduction of life for expansion. Human bodies and subjects are playing a role similar to that of land and natural resource dispossession in the period of capitalist growth during European territorial colonialism. Indeed, the rapid pace at which scientific knowledge of biology and genetics has accelerated has opened up the human body as an extended site for annexation, harvest, dispossession, and production.

Focusing on the period between the 1970s and the present, Life as Surplus is a pointed and important study of the relationship between politics, economics, science, and cultural values in the United States today. Melinda Cooper demonstrates that the history of biotechnology cannot be understood without taking into account the simultaneous rise of neoliberalism as a political force and an economic policy. From the development of recombinant DNA technology in the 1970s to the second Bush administration's policies on stem cell research, Cooper connects the utopian polemic of free-market capitalism with growing internal contradictions of the commercialized life sciences. The biotech revolution relocated economic production at the genetic, microbial, and cellular level. Taking as her point of departure the assumption that life has been drawn into the circuits of value creation, Cooper underscores the relations between scientific, economic, political, and social practices. In penetrating analyses of Reagan-era science policy, the militarization of the life sciences, HIV politics, pharmaceutical imperialism, tissue engineering, stem cell science, and the pro-life movement, the author examines the speculative impulses that have animated the growth of the bioeconomy. At the very core of the new post-industrial economy is the transformation of biological life into surplus value. Life as Surplus offers a clear assessment of both the transformative, therapeutic dimensions of the contemporary life sciences and the violence, obligation, and debt servitude crystallizing around the emerging bioeconomy.

This book addresses the unprecedented convergence between the digital and the corporeal in the life sciences and turns to Foucault’s biopolitics in order to understand how life is being turned into a technological object. It examines a wide range of bioscientific knowledge practices that allow life to be known through codes that can be shared (copied), owned (claimed, and managed) and optimised (remade through codes based on standard language and biotech engineering visions). The book’s approach is captured in the title, which refers to 'the biopolitical'. The authors argue that through discussions of political theories of sovereignty and related geopolitical conceptions of nature and society, we can understand how crucially important it is that life is constantly unsettling and disrupting the established and familiar ordering of the material world and the related ways of thinking and acting politically. The biopolitical dynamics involved are conceptualised as the 'metacode of life', which refers to the shifting configurations of living materiality and the merging of conventional boundaries between the natural and artificial, the living and non-living. The result is a globalising world in which the need for an alternative has become a core part of its political and legal instability, and the authors identify a number of possible alternative platforms to understand life and the living as framed by the 'metacodes' of life. This book will appeal to scholars of science and technology studies, as well as scholars of the sociology, philosophy, and anthropology of science, who are seeking to understand social and technical heterogeneity as a characteristic of the life sciences.

The first scholarly exploration of the forums, practice, and economics of functional medicine. Physicians of the Future interrogates the hidden logics of inclusion and exclusion in functional medicine (FM), a holistic form of personalized medicine that targets chronic disease. Rosalynn Vega uncovers how, as “wounded healers,” some FM practitioners who are former chronic disease sufferers turn their illness narratives into a form of social capital, leveraging social media to relate to patients and build practices as “doctor-influencers.” Arguing that power and authority operate distinctly in FM when compared to conventional medicine, largely because FM services are paid for out of pocket by socioeconomically privileged “clients,” Vega studies how FM practitioners engage in entrepreneurship of their own while critiquing the profit motives of the existing healthcare system, pharmaceutical industry, and insurance industry. Using data culled from online support groups, conferences, docuseries, blogs, podcasts, YouTube, and TED Talks, as well as her own battles with chronic illness, Vega argues that FM practices prioritize the individual while inadvertently reinscribing inequities based on race and class. Ultimately, she opens avenues of possibility for FM interlocutors wrestling with their responsibility for making functional medicine accessible to all.

The advancement of the life sciences and the technosciences has enhanced the longevity of citizens in the Western world, and half of the generation born in the first decade of the new millennium is now expected to live to the age of one hundred years. In a society with such longevity and affluence, consumption of health-related goods and services such as pharmaceuticals and scanning procedures may be seen as a sustainable source of income for the industries that promote it. Though the healthcare sector has traditionally been organized in the public sector in Europe and in the private sector in the US, the recent advancement of new therapies and direct-to-consumer marketing have opened up new streams of consumption and revenue for health care goods and services around the globe. This book examines the so-called ‘bioeconomy’ as a new economic and commercial field that emphasizes the management of individual life, including the regulation and control of weight and food consumption and other issues pertaining to individual well-being. In addition, the bioeconomy includes a variety of practices based on commercial interests such as organ donations, reproductive medicine and technologies, and what has been referred to as the tissue economy – the various forms of trade with human tissues. Author Alexander Styhre provides a thorough introduction to the bioeconomy, exploring this new and unique intersection of the life sciences and the technosciences with more traditional consumer markets.

But today normality itself is open to medical modification.